BridgeBio Oncology Therapeutics, Inc. (BBOT) has 6 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 14, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 14, 2026 filed Sept. 10, 2026 | Cobo Marc Principal Accounting Officer | — | +8,835 | +25% | No | |
|
|
||||||
| July 6, 2026 filed July 1, 2026 | Cobo Marc Principal Accounting Officer | $975 | 125 | −2% | No | |
|
|
||||||
| July 6, 2026 filed July 1, 2026 | Elmelech Idan COO & Principal Financial Ofcr | $2,675 | 343 | −2% | No | |
|
|
||||||
| July 6, 2026 filed July 1, 2026 | Beltran Pedro President and CEO | $8,167 | 1,047 | −2% | No | |
|
|
||||||
| July 6, 2026 filed July 1, 2026 | Ben Yong Chief Med & Dev Officer | $8,167 | 1,047 | −2% | No | |
|
|
||||||
Showing the 5 most recent of 6 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free